Cardiovascular responses and interactions by neuropeptide Y in rats with congestive heart failure

Blood Pressure

Volumn 5, Issue 5, 1996, Pages 312-318

  Feng, Qing Ping ^b   Sun, Xiang Ying ^a   Hedner, Thomas ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Angiotensin II; Blood pressure; Congestive heart failure (CHF); Endothelin 1; Heart rate; Neuropeptide Y (NPY); Phenylephrine; Tyramine

Indexed keywords

ANGIOTENSIN; ENDOTHELIN; NEUROPEPTIDE Y; PHENYLEPHRINE; TYRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CARDIOVASCULAR RESPONSE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOSE RESPONSE; HEART RATE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; VASODILATATION;

EID: 0029765561     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059609078065     Document Type: Article

References (40)

1. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y - A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982; 296: 659-60.
2. Lundberg JM, Fried G, Pernow J, Theodorsson-Norheim E. Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat. Acta Physiol Scand 1986; 126: 231-8.
3. Wahlestedt C, Yanaihara N, Hakanson R. Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides. Regul Pep 1986; 13: 307-18.
4. Edvinsson L, Ekblad E, Hakanson R, Wahlestedt C. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol 1984; 83: 519-25.
5. Dahlof C, Dahlof P, Lundberg JM. Neuropeptide Y (NPY): enhancement of blood pressure increase upon alpha-adrenoceptor activation and direct pressor effects in pithed rats. Eur J Pharmacol 1985; 109: 289-92.
6. 2, NPY and angiotensin II receptors. Naunyn-Schiedeberg's Arch Pharmacol 1989; 340: 379-85.
7. Dahlof P, Persson K, Lundberg JM, Dahlof C. Neuro-peptide Y (NPY) induced inhibition of preganglionic nerve stimulation evoked release of adrenaline and noradrenaline in the pithed rat. Acta Physiol Scand 1988; 132: 51-7.
8. Westfall TC, Carpentier S, Chen X, Beinfeld MC, Naes L, Meldrum MJ. Prejunctional and postjunctional effects of neuropeptide Y at the noradrenergic neuroeffector junction of the perfused mesenteric artery bed of the rat. J Cardiovasc Pharmacol 1987; 10: 716-22.
9. Aubert JF, Waeber B, Rossier B, Geering K, Nussberger J, Brunner HR. Effects of neuropeptide Y on the blood pressure response to various vasoconstrictor agents. J Pharmacol Exp Ther 1988; 246: 1088-92.
10. DiBona GF, Herman PJ, Sawin LL. Neural control of renal function in edema forming states. Am J Physiol 1988; 254: R1017-24.
11. Feng QP, Carlsson S, Thoren P, Hedner T. Characteristics of renal sympathetic nerve activity in experiment congestive heart failure in the rats. Acta Physiol Scand 1994; 150: 259-66.
12. Lcimbach WN, Wallin BG, Victor GR, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings of increased central sympathetic outflow in patients with heart failure. Circulation 1986; 73: 913-19.
13. Francis GS, Goldsmiths R, Levine TB, Olivari MR, Cohn JN. The neurohumoral axis in congestive heart failure. Ann Intern Med 1984; 101: 370-77.
14. Hasking GJ, Esler MD, Jennings GL, Burton D, Korner PI. Spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardio-renal sympathetic nervous activity. Circulation 1986; 73: 615-21.
15. Caidahl K., Hedner J. Atrial natriuretic peptide (ANP) and catecholamines in peripheral blood as indicators of cardiac dysfunction on the seneral population. Clin Sci 1988; 74: 587-94.
16. Maisel AS, Scott MA, Motulsky HJ, Michel MC, Boublik JH, Rivier JE, et al. Elevation of plasma neuropeptide Y levels in congestive heart failures. Am J Med 1989; 86: 43-8.
17. Hulting J, Sollevi A, Ullman B, Franco-Cereceda A, Lundberg JM. Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure. Cardiovasc Res 1990; 24: 102-8.
18. Feng QP, Hedner T, Andersson B, Lundberg JM, Waagstein F. Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure. Br Heart J 1994; 71: 261-7.
19. Edvinsson L, Ekman R, Hedner P, Valdemarsson S. Congestive heart failure: involvement of perivascular peptides reflecting activity in sympathetic, parasympathetic and afferent fibres. Eur J Clin Invest 1990; 20: 85-9.
20. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation 1992; 85: 1374-9.
21. Margulies KB, Hildebrand FL, Lerman A, Perella MA, Burnett JC. Increased endothelin in experimental heart failure. Circulation 1990; 82: 2226-30.
22. Feng QP, Lu XR, Bergdahl A, Sun XY, Edvinsson L, Hedner T. Vascular alpha-2 adrenoceptor function is decreased in rats with congestive heart failure. Cardiovasc Res 1996 (in press).
23. Fu LX, Sun XY, Hedner T, Feng QP, Liang QM, Hoebeke J, Hjalmarson A. Decreased density of mesenteric arteries but not of myocardial endothelin receptors and function in rats with chronic ischemic heart failure. J Cardiovasc Pharmacol 1993; 22: 177-82.
24. Bergdahl A, Valdemarsson S, Pantev E, Ottosson A, Feng QP, Sun XY, et al. Modulation of vascular contractile response to a1- and a2-adrenergic and neuropeptide Y receptor stimulation in rats with ischaemic heart failure. Acta Physiol Scand 1995; 154: 429-37.
25. Gardiner SM, Compton AM, Bennett T. Regional haemodynamic effects of endothelin-1 in conscious, unrestrained Wistar rats. J Cardiovasc Pharmacol 1989; 13 (Suppl 5): S202-4.
26. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979; 44: 503-12.
27. Feng QP, Hedner T, Hedner J, Pettersson A. Blunted renal response to atrial natriuretic peptide in congestive heart failure rats is reversed by the α2-adrenergic agonist clonidine. J Cardiovasc Pharmacol 1990; 16: 776-82.
28. Sun XY, Edvinsson L, Hedner T. Effects of d-myoinositol-1.2.6-trisphosphate on neuropeptide Y induced potentiation of various vasoconstrictor agents in the rat. J Pharmacol Exp Ther 1992; 261: 1147-52.
29. Feng QP, Carlsson S, Thoren P, Hedner T. Effects of clonidine on renal sympathetic nerve activity, natriuresis and diuresis in chronic consestive heart failure rats. J Pharmacol Exp Ther 1992; 261: 776-82.
30. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980; 47: 1-9.
31. Hieble JP, Dusler JG, Daly RN. Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation. J Pharmacol Exp Ther 1989; 250: 523-8.
32. Glover WE. Increased sensitivity of rabbit ear artery to noradrenaline following perivascular nerve stimulation may be a response to neuropeptide Y released as co-transmitter. Clin Exp Pharmacol Physiol 1985; 12: 227-30.
33. Wahlestedt C, Edvinsson L, Ekblad E, Hakanson R. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther 1985, 234: 735-41.
34. MacLean MR, McGrath JC. Effects of pre-contraction with endothelin-1 on α2-adrenoceptor and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated vascular bed of the rat tail. Br J Pharmacol 1990; 101: 205-11.
35. The CONSENSUS trial group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429-35.
36. Pfeffer MA, Braunwald E, Move LA, Basta L, Brown EJJ, Cuddy TE, et al. on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327: 669-77.
37. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by endothelial cells. Nature 1988; 332: 411-15.
38. Yanagisawa M, Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci 1989; 10: 374-78.
39. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci 1992; 13: 103-8.
40. Drexler H, Lu W. Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure. Am J Physiol 1992; 262: H1640-5.